LONG-TERM EVALUATION OF SAFETY AND EFFICACY OF PITOLISANT (WAKIX®), AN HISTAMINE H3R ANTAGONIST, IN NARCOLEPSY

被引：0
|
作者：
Dauvilliers, Y. [1 ]
Arnulf, I. [2 ]
Szakacs, Z. [3 ]
Scart-Gres, C. [4 ]
Lecomte, I. [4 ]
Causse, C. [4 ]
Schwartz, J-C. [4 ]
机构：
[1] Hop Gui de Chauliac, Serv Neurol, Montpelliers, France
[2] Grp Hosp Pitie Salpetriere, Federat Pathol Sommeil, Paris, France
[3] Natl Hlth Ctr, Budapest, Hungary
[4] Bioprojet, Paris, France
来源：
SLEEP MEDICINE | 2017年 / 40卷
关键词：
D O I：
10.1016/j.sleep.2017.11.215
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E75 / E75
页数：1
相关论文
共 50 条
  • [1] LONG-TERM EVALUATION OF SAFETY AND EFFICACY OF PITOLISANT IN NARCOLEPSY: HARMONY 3 STUDY
    Dauvilliers, Y.
    Arnulf, I.
    Scart-Gres, C.
    Lecomte, I.
    Causse, C.
    Dayno, J.
    Schwartz, J. -C.
    SLEEP MEDICINE, 2019, 64 : S85 - S85
  • [2] Long-Term Evaluation of Safety and Efficacy of Pitolisant in Narcolepsy: HARMONY 3 Study
    Dauvilliers, Yves
    Arnulf, Isabelle
    Szakacs, Zoltan
    Scart-Gres, Catherine
    Lecomte, Isabelle
    Causse, Christian
    Schwartz, Jean-Charles
    NEUROLOGY, 2019, 92 (15)
  • [3] LONG-TERM EVALUATION OF SAFETY AND EFFICACY OF PITOLISANT IN NARCOLEPSY: HARMONY III STUDY
    Dauvilliers, Y.
    Arnulf, I
    Szakacs, Z.
    Scart-Gres, C.
    Lecomte, I
    Causse, C.
    Schwartz, J.
    SLEEP, 2018, 41 : A231 - A232
  • [4] TOLERANCE AND PHARMACOKINETICS OF PITOLISANT (WAKIX®), A HISTAMINE H3 ANTAGONIST, IN 24 NARCOLEPTIC CHILDREN
    Lecendreux, M.
    Plazzi, G.
    Franco, P.
    Robert, P.
    Duvauchelle, T.
    Lecomte, J. -M.
    SLEEP MEDICINE, 2017, 40 : E182 - E182
  • [5] Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy
    A. A. Hancock
    M. S. Diehl
    T. A. Fey
    E. N. Bush
    R. Faghih
    T. R. Miller
    K. M. Krueger
    J. K. Pratt
    M. D. Cowart
    R. W. Dickinson
    R. Shapiro
    V. E. Knourek-Segel
    B. A. Droz
    C. A. McDowell
    G. Krishna
    M. E. Brune
    T. A. Esbenshade
    P. B. Jacobson
    Inflammation Research, 2005, 54 : S27 - S29
  • [6] Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy
    Hancock, AA
    Diehl, MS
    Fey, TA
    Bush, EN
    Faghih, R
    Miller, TR
    Krueger, KM
    Pratt, JK
    Cowart, MA
    Dickinson, RW
    Shapiro, R
    Knourek-Segel, VE
    Droz, BA
    McDowell, CA
    Krishna, G
    Brune, ME
    Esbenshade, TA
    Jacobson, PB
    INFLAMMATION RESEARCH, 2005, 54 (Suppl 1) : S27 - S29
  • [7] Tolerance and pharmacokinetics of pitolisant (Wakix®), a histamine H3 antagonist, in 24 narcoleptic children
    Lecendreux, M.
    Plazzi, G.
    Franco, P.
    Robert, P.
    Duvauchelle, T.
    Lecomte, J. -M.
    JOURNAL OF SLEEP RESEARCH, 2016, 25 : 230 - 231
  • [8] ANTICATAPLECTIC EFFICACY OF WAKIX® (PITOLISANT), THE FIRST POTENT AND HIGHLY SELECTIVE HISTAMINE H3-RECEPTOR ANTAGONIST/INVERSE AGONIST IN CLINICS
    Schwartz, J. -C.
    Lecomte, J. -M.
    Causse, C.
    SLEEP MEDICINE, 2017, 40 : E297 - E297
  • [9] Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant, BF2.649) in epilepsy: Dose-dependent effects in the human photosensitivity model
    Trenite, Dorothee Kasteleijn-Nolst
    Parain, Dominique
    Genton, Pierre
    Masnou, Pascal
    Schwartz, Jean-Charles
    Hirsch, Edouard
    EPILEPSY & BEHAVIOR, 2013, 28 (01) : 66 - 70
  • [10] Evaluation of A-331440 analogs with improved safety and efficacy potential as antiobesity histamine H3 receptor (H3R) antagonists
    Hancock, AA
    Diehl, MS
    Krishna, G
    Miller, TR
    Krueger, KM
    Pratt, JK
    Faghih, R
    Bennani, YL
    Cowart, MD
    Esbenshade, T
    FASEB JOURNAL, 2004, 18 (04): : A574 - A575
12345